1. Piette WW. Morphea or localized scleroderma. In: Clements PJ, Furst DE, eds. Systemic sclerosis. Philadelphia: Lippincott Williams & Wilkins; 2004:29–37.
2. Medsger TA Jr. Classification, prognosis. In: Clements PJ, Furst DE, eds. Systemic sclerosis. Philadelphia: Lippincott Williams & Wilkins; 2004:17–28.
3. Korn JH. Pathogenesis of systemic sclerosis. In: Koopman WJ, Moreland LW, eds. Arthritis and allied conditions. Philadelphia: Lippincott Williams & Wilkins; 2005:1621–1632.
4. Boin F, Wigley FM. Understanding, assessing and treating Raynaud’s phenomenon. Curr Opin Rheumatol 2005;17:752–760.
5. Fraenkel L, Zhang Y, Chaisson CE, et al. Different factors influencing the expression of Raynaud’s phenomenon in men and women. Arthritis Rheum 1999;42:306–310.